1.) Lin F,
Zhang S,
Sun Y,
Ren S,
Liu P.
The management of varicose veins.
International surgery.
2015 Jan;100(1):185-9.
2.) Campbell B.
Varicose veins and their management.
Bmj.
2006 Aug 3;333(7562):287-92.
3.) Callam MJ.
Epidemiology of varicose veins. Br J Surg. 1994;81:167–173.
4.) Robertson L,
Evans C,
Fowkes FG.
Epidemiology of chronic venous disease.
Phlebology.
2008;23:103–111.
5.) Maurins U,
Hoffmann BH,
Lösch C,
Jöckel KH,
Rabe E,
Pannier F.
Distribution and prevalence of reflux in the superficial and deep venous system in the general population – results from the Bonn Vein Study,
Germany. J Vasc Surg. 2008;48:680–687.
6.) Evans C,
Fowkes FG,
Ruckley CV,
Lee A.
Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. J Epidemiol Community Health. 1999;53:149–153.
7.) Lifestyle factors and the risk of varicose veins: Edinburgh Vein Study.
Lee AJ,
Evans CJ,
Allan PL,
Ruckley CV,
Fowkes FG J Clin Epidemiol.
2003 Feb; 56(2):171-9.
8.) Ren S,
Liu P.
Initial clinical experiences in treating 27 cases of varicose veins with EVLT plus TRIVEX. J US China Med Sci. 2005;2(1):4–8.
9.) Catarinella FS,
Nieman FH,
Wittens CH.
An overview of the most commonly used venous quality of life and clinical outcome measurements.
Journal of Vascular Surgery: Venous and Lymphatic Disorders.
2015 Jul 31;3(3):333-40.
10.) Perrin MR,
Guex JJ,
Ruckley CV,
de Palma RG,
Royle JP,
Eklof B,
Nicolini P,
Jantet G.
Recurrent varices after surgery (REVAS): a consensus document.
REVAS Group. Cardiovasc Surg. 2000;8:233–245.
11.) Campbell WB,
Vijay Kurnar A,
Collin TW,
Allington KL,
Michaels JA.
Outcome of varicose vein surgery at 10 years: clinical findings,
symptoms and patient satisfaction. Ann R Coll Surg Engl. 2003;85:52–57.
12.) Perkins JM.
Standard varicose vein surgery. Phlebology. 2009;24:34–41.
13.) Critchley G,
Handa A,
Maw A,
Harvey A,
Harvey MR,
Corbett CR.
Complications of varicose vein surgery. Ann R Coll Surg Engl. 1997;79:105–110.
14.) EliAS S.
Emerging endovenous therapies.
Endovascular Today,
March.
2014.
15.) Proebstle TM,
Alm J,
Gockeritz O,
et al.
Three year European follow-up of endovenous radiofrequencypowered segmental thermal ablation of the great saphenous vein with or without treatment of calf varicosities.
J Vasc Surg.
2011;52:1-7.
16.) Rasmussen LH,
Lawaetz M,
Bjoern L,
Vennits B,
Blemings A,
Eklof B.
Randomized clinical trial of endovenous laser ablation,
radiofrequency ablation,
foam sclerotherapy and surgical stripping for great saphenous varicose veins. Br J Surg. 2011;98:1079–1087.
17.) Subramonia S,
Lees T.
Randomized clinical trial of radiofrequency ablation or conventional ligation and stripping for great saphenous varicose veins. Br J Surg. 2010;97:328–336.
18.) Siribumrungwong B,
Noorit P,
Wilasrusmee C,
et al. A systematic review and meta-analysis of randomised controlled trials comparing endovenous ablation and surgical intervention in patients with varicose vein. Eur J Vasc Endovasc Surg2012; 44: 214–223.
19.) Sichlau MJ,
Ryu RK. Cutaneous thermal injury after endovenous laser ablation of the great saphenous vein. J Vasc Interv Radiol 2004; 15: 865–867.
20.) Van Den Bos RR,
Neumann M,
De Roos KP,
et al. Endovenous laser ablation-induced complications: review of the literature and new cases. Dermatol Surg2009; 35: 1206–1214.
21.) Bellam Premnath KP,
Joy B,
Raghavendra VA,
Toms A,
Sleeba T.
Cyanoacrylate adhesive embolization and sclerotherapy for primary varicose veins.
Phlebology.
2017 Jan 1:0268355517733339.
22.) Proebstle T,
Alm J,
Gockeritz O,
et al.
One year follow up of the European Multicenter Study on cyanoacrylate embolization of incompetent great saphenous veins.
International Union of Phlebology World Meeting; September 8–13,
2013; Boston,
MA.
23.) Tang TY,
Kam JW,
Gaunt ME.
ClariVein®–Early results from a large single-centre series of mechanochemical endovenous ablation for varicose veins.
Phlebology.
2017 Feb;32(1):6-12.
24.) Deijen CL,
Schreve MA,
Bosma J,
et al. Clarivein mechanochemical ablation of the great and small saphenous vein: early treatment outcomes of two hospitals. Phlebology 2015.
2016; 31: 192–197.
25.) van Eekeren RR,
Boersma D,
Holewijn S,
Vahl A,
de Vries JP,
Zeebregts CJ,
Reijnen MM.
Mechanochemical endovenous Ablation versus RADiOfrequeNcy Ablation in the treatment of primary great saphenous vein incompetence (MARADONA): study protocol for a randomized controlled trial.
Trials.
2014 Dec 1;15(1):121.
26.) Elias S,
Raines JK.
Mechanochemical tumescentless endovenous ablation: final results of the initial clinical trial.
Phlebology.
2012 Mar;27(2):67-72.
27.) Boersma D,
van Eekeren RR,
Werson DA,
et al. Mechanochemical endovenous ablation of small saphenous vein insufficiency using the ClariVein® device: one-year results of a prospective series. Eur J Vasc Endovasc Surg 2013; 45: 299–303.
28.) Elias S,
Lam YL,
Wittens CHA.
Mechanochemical ablation: status and results.
Phlebology.
2013;28(suppl 1):10-14.
29.) Vun S,
Rashid S,
Blest N,
Spark J. Lower pain and faster treatment with mechanico-chemical endovenous ablation using ClariVein®. Phlebology 2014; 30: 688–692.
30.) Bootun R,
Lane T,
Dharmarajah B,
et al. Intra-procedural pain score in a randomised controlled trial comparing mechanochemical ablation to radiofrequency ablation: the multicentre venefit versus ClariVein® for varicose veins trial. Phlebology 2014; 31: 61–65.
31.) Sun JJ,
Chowdhury MM,
Sadat U,
Hayes PD,
Tang TY.
Mechanochemical Ablation for Treatment of Truncal Venous Insufficiency: A Review of the Current Literature.
Journal of Vascular and Interventional Radiology.
2017 Oct 1;28(10):1422-31.
32.) Parsi K.
Paradoxical embolism,
stroke and sclerotherapy.
Phlebology.
2012 Jun;27(4):147-67.
33.) Raymond-Martimbeau P.
Air embolism complications associated with sclerotherapy.
Phlébologie.
2012 Sep 1;65(3):20-7.